Tag Archives: Could

Novartis’ new cell therapy facility could ease manufacturing squeeze for CAR-T med Kymriah

Novartis’ big push into cell and gene therapy hasn’t been the smoothest of rides, with a data manipulation scandal hamstringing Zolgensma and manufacturing concerns hurting CAR-T cancer therapy Kymriah. Could a new European facility help turn around the latter’s production bottleneck?  Novartis last week opened its newest cell and gene therapy facility in Stein, Switzerland,… Read More »

CDC officials worry E. coli outbreak could spread over Thanksgiving

A produce worker stocks shelves near romaine lettuce (top shelf, right) at a supermarket in Washington, DC on November 20, 2018. Andrew Caballero-Reynolds | AFP | Getty Images The Centers for Disease Control and Prevention is warning consumers to check the labels of romaine lettuce and salad mixes they plan to serve at Thanksgiving dinner,… Read More »

New blood test could be used to help millions infected with TB

Protein power The research team set out to create their blood-based test by identifying a signature set of biomarkers in patients’ blood that consistently indicated a high likelihood of ATB, then developing an easily deployable assay that could detect that signature. They first measured the levels of 47 different blood proteins in about 400 samples… Read More »